Effectiveness of Point-of-use Water Treatment Technologies to Prevent Stunting Among Children in South Africa
NCT ID: NCT03012048
Last Updated: 2025-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
415 participants
INTERVENTIONAL
2016-06-30
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rural Appalachia Pilot Water Treatment Trial
NCT06120985
Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
NCT01695304
WASH Benefits Bangladesh
NCT01590095
Water-based Zinc Intervention Trial in Zinc Deficient Children
NCT01472211
Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health
NCT02396407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Households in the Dzimauli community will be randomized to receive the ceramic disk, a water filter, the safe-storage water container alone, or no intervention. Children will be followed every three months for 2 years to assess height, weight, and pathogen burden in stool samples. Cognitive assessments will be completed at 2, 5, and 7 years of follow-up. The investigators hypothesize that children in households given the ceramic disk or the water filter will show improved linear growth compared to those in households without these interventions. The investigators expect that the ceramic disk will perform similarly to the water filter and result in similar improvements in linear growth when compared to children from control households.
Estimates of effectiveness demonstrated in this trial will provide the necessary evidence base to support the scale-up of manufacturing and distribution of the ceramic disks and filters, which could provide a robust point-of-use water treatment solution for rural areas. By helping to identify effective tools to reduce the risk of stunting in children, the trial will contribute to targets to improve child health in low-resource settings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MadiDrop (ceramic tablet)
Households receive a MadiDrop (silver-impregnated ceramic tablet) in a safe-storage water container to use for all drinking water needs in the household. MadiDrops are replaced every 6 months over the 2-year intervention study period.
In July 2017, all households in the MadiDrop arm were crossed over to the ceramic water filter arm due to inconsistent silver release from the ceramic tablets.
Silver-impregnated ceramic tablet
A silver-impregnated ceramic disk used for drinking water treatment that was developed by engineers at the University of Virginia. When the ceramic disk is placed in a household water storage container, silver diffuses through the porous ceramic into the water at a release rate that is effective for continual disinfection of waterborne pathogens while remaining below the silver drinking water standard. The disk is effective for daily treatment of 10 to 15 liters for at least six months.
This intervention was removed from the study in July 2017 (approximately at 1 year of follow-up).
Silver-impregnated ceramic water filter
Households receive a silver-impregnated ceramic filter in a safe-storage water container to use for all drinking water needs in the household. Filters are replaced at the end of the 2-year intervention study period.
In December 2017, all silver-impregnated ceramic water filters were replaced with the same ceramic filters without silver due to continued inconsistencies with silver release.
Silver-impregnated ceramic water filter
Silver-impregnated ceramic water filter are well-developed, tested, and widely-used devices. In addition to mechanically removing pathogens, the filter is treated with silver to reduce live pathogens that pass through the filter and to provide residual disinfectant to reduce risk of recontamination after treatment.
This intervention was replaced with ceramic filters without silver in Dec 2017 (approximately at 1.5 years of follow-up).
Safe-storage water container
Households receive a safe-storage water container alone to use for all drinking water needs in the household.
Safe-storage water container
The safe-storage water containers used in this study are plastic buckets with a spigot, purchased locally.
No intervention
Households are encouraged to continue their usual water treatment practices.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Silver-impregnated ceramic tablet
A silver-impregnated ceramic disk used for drinking water treatment that was developed by engineers at the University of Virginia. When the ceramic disk is placed in a household water storage container, silver diffuses through the porous ceramic into the water at a release rate that is effective for continual disinfection of waterborne pathogens while remaining below the silver drinking water standard. The disk is effective for daily treatment of 10 to 15 liters for at least six months.
This intervention was removed from the study in July 2017 (approximately at 1 year of follow-up).
Silver-impregnated ceramic water filter
Silver-impregnated ceramic water filter are well-developed, tested, and widely-used devices. In addition to mechanically removing pathogens, the filter is treated with silver to reduce live pathogens that pass through the filter and to provide residual disinfectant to reduce risk of recontamination after treatment.
This intervention was replaced with ceramic filters without silver in Dec 2017 (approximately at 1.5 years of follow-up).
Safe-storage water container
The safe-storage water containers used in this study are plastic buckets with a spigot, purchased locally.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The child's caregiver is at least 16 years of age
Exclusion Criteria
* The household currently uses a ceramic filter or other commercial water treatment technology (including a permanent, engineered system that treats the water through filtration and/or chlorination)
* The household has plans to move outside the community in the next 6 months
* The youngest child under 3 years of age is seriously ill (has a severe disease requiring prolonged hospitalization or a severe or chronic condition diagnosed by medical doctor, e.g. neonatal disease, renal disease, chronic heart failure, liver disease, cystic fibrosis, congenital conditions)
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Venda
UNKNOWN
University of Virginia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascal O Bessong, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Venda, Limpopo, South Africa
Rebecca Dillingham, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Virginia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Venda
Thohoyandou, Limpopo, South Africa
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Commercial website describing the main experimental device in this trial
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-HSR 18662
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.